Benchmark equity indices ended lower on Wednesday after three days of gain amid profit-taking ahead of the June inflation print, which came in higher owing to high food prices.Fag-end selling pulled down 30-share BSE Sensex by 223.94 points or 0.34% to settle at 65,393.90.Nifty closed below 19,400 levels, with a cut of 55 points or … Read more
Mankind Pharma, a recent entrant to the stock exchanges, has been included in several Nifty indices, including Nifty500, Nifty Midcap150, Nifty Midcap100 and Nifty200. The decision was taken at a meeting of the index maintenance sub-committee. Mankind Pharma, whose IPO was one of the largest this year, made a healthy debut on the exchanges in … Read more
Brokerage firms such as Jefferies initiated a hold rating on Mankind Pharma, Bernstein upgraded Delhivery to outperform, ICICI Securities initiated coverage on Suzlon with a buy rating and Motilal Oswal maintained a buy rating on ICICI Lombard. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Motilal Oswal … Read more
Kotak Institutional Equities initiated coverage on Mankind Pharma stock with ‘Add’ rating for a price target of Rs 1,875. The domestic brokerage sees an 11% upside in the counter from current levels. “Mankind Pharma is well-positioned to further leverage its robust marketing prowess and reach. Within branded Rx, we expect a ramp-up of specialty and … Read more
Indian equity indices, tracking world markets, ended on a solid note near record highs on Wednesday amid bets that the Federal Reserve may announce a rate pause in its policy outcome late at night. Sector-wise, metal pack topped, while there was seen selling pressure in private banking and financial services basket. Here’s how analysts read … Read more
Poonam Juneja, director of Mankind Pharma recently sold a property in Delhi’s Vasant Vihar for Rs 91 crore. Spread over 1,200 square yards, the bungalow was bought by Dhruv Malhotra, Dakhsh Malhotra, and Ranjana Malhotra of Everest Pressure and Vacuum Systems. As per reports, they had to pay a stamp duty of Rs 4.85 crore. … Read more
Infosys, NTPC and Hindustan Unilever were among the top large-cap stocks fancied by mutual funds in April, while reducing positions in SBI, Axis Bank and ICICI Bank. Overall, in the reporting month, mutual funds sold stocks worth Rs 5,100 crore while FIIs bought Rs 12,400 worth stocks in the secondary market, according to a report … Read more
“We called out at the beginning of the year itself that you will see a bulk of the returns coming in the market in the second half of the year and that is what we are prepared for,” says Dinshaw Irani, CIO, Helios India.One-third of the total cloud opportunity has only been implemented in terms … Read more
Shares of Mankind Pharma will hit the Street on May 9 and grey market trends indicate a healthy listing for the company. According to market sources, the shares of Mankind Pharma are commanding a premium of Rs 120 apiece. Considering the upper price band of Rs 1,080, the company’s shares are expected to list a … Read more
The initial share sale of Mankind Pharma will open for subscription on Tuesday and will be available for public to bid till April 27. Ahead of the subscription, the issue will be open for anchor investors on Monday. The company has fixed a price band of Rs 1,026-1,080 for its IPO, which is completely an … Read more